Federal Reserve Economic Data

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Liabilities and Stockholders' Equity (QFR328385USNO)

Q4 2024: 1,780,316
Updated: Mar 24, 2025 9:08 AM CDT
Q4 2024:  1,780,316  
Q3 2024:  1,821,560  
Q2 2024:  1,807,151  
Q1 2024:  1,805,175  
Q4 2023:  1,799,263  
View All

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

Fullscreen

Notes

Source: U.S. Census Bureau  

Release: Quarterly Financial Report  

Units:  Millions of Dollars, Not Seasonally Adjusted

Frequency:  Quarterly

Notes:

Further information related to the Quarterly Financial Report survey can be found at https://www.census.gov/econ/qfr/about.html
Methodology details can be found at https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf

Suggested Citation:

U.S. Census Bureau, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Liabilities and Stockholders' Equity [QFR328385USNO], retrieved from FRED, Federal Reserve Bank of St. Louis; https://fred.stlouisfed.org/series/QFR328385USNO, .

Related Data and Content


Subscribe to the FRED newsletter


Follow us

Back to Top